Share Price and Basic Stock Data
Last Updated: January 22, 2026, 8:52 am
| PEG Ratio | -10.13 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bhagiradha Chemicals & Industries Ltd operates in the agrochemical and pesticides sector, with a market capitalization of ₹2,683 Cr. The company reported sales of ₹502 Cr for the fiscal year ending March 2023, which marked a growth from ₹436 Cr in the previous year. However, the sales figure is expected to decline to ₹407 Cr in FY 2024, reflecting challenges in maintaining revenue momentum. Quarterly sales have shown fluctuations, peaking at ₹131.81 Cr in September 2022, but dropping to ₹100.01 Cr by June 2023, before recovering to ₹122.01 Cr in September 2023. This inconsistent sales performance highlights potential volatility in market demand and operational stability. The company’s operational profit margin (OPM) stood at 10.58%, indicating a moderate level of profitability relative to its sales. The trailing twelve months (TTM) sales figure of ₹484 Cr suggests a recovery trend, but the decline in annual sales expectations raises concerns about future growth prospects.
Profitability and Efficiency Metrics
Bhagiradha Chemicals reported a net profit of ₹26 Cr for FY 2025, declining from ₹46 Cr in FY 2023. The company’s P/E ratio of 101 is significantly higher than the typical sector average, indicating that investors are paying a premium for the stock, possibly due to growth expectations that have yet to materialize. The return on equity (ROE) stood at 4.91%, while return on capital employed (ROCE) was reported at 7.44%, both of which are below the industry averages and suggest inefficiencies in capital utilization. The company’s cash conversion cycle (CCC) of 169 days highlights challenges in managing working capital effectively, with debtor days increasing to 145 and inventory days at 158. The pressure on profitability is evident from the declining operating profit margins, which fell to 5.90% in March 2025, compared to 16% in March 2023, reflecting rising costs and operational inefficiencies.
Balance Sheet Strength and Financial Ratios
Bhagiradha Chemicals has a robust balance sheet with total reserves amounting to ₹699 Cr as of September 2025. The company’s borrowings stood at ₹93 Cr, resulting in a low long-term debt-to-equity ratio of 0.04, indicating a conservative financial structure. However, the interest coverage ratio (ICR) of 6.50x suggests that the company can comfortably meet its interest obligations. The price-to-book value (P/BV) ratio of 5.28x indicates that the stock is trading at a premium relative to its book value, which may raise concerns among value investors. The current ratio of 1.92x reflects a healthy liquidity position, allowing the company to cover its short-term liabilities. However, the increasing total liabilities, which stood at ₹932 Cr in September 2025, may pose risks if not managed carefully, especially in a volatile market environment.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bhagiradha Chemicals reveals a strong public presence, with public shareholders holding 77.48% of the company as of September 2025. Promoters’ holdings have gradually declined to 19.60%, raising questions about their confidence in the company’s future. Foreign institutional investors (FIIs) hold a mere 0.05%, while domestic institutional investors (DIIs) account for 2.89%. This low institutional interest may reflect skepticism regarding the company’s growth trajectory and operational challenges. The number of shareholders has fluctuated, standing at 13,761, indicating a diversified investor base. The declining promoter stake and minimal institutional ownership may affect investor sentiment, potentially leading to increased volatility in the stock price, especially if the company fails to demonstrate sustainable growth and profitability.
Outlook, Risks, and Final Insight
Looking ahead, Bhagiradha Chemicals faces a mixed outlook characterized by both opportunities and challenges. The company must focus on improving operational efficiencies and stabilizing revenue streams to regain investor confidence. Key risks include fluctuating demand in the agrochemical sector, rising costs affecting margins, and the potential for increased competition. Should the company execute effective cost management and enhance its product offerings, it may reverse its declining trends. Conversely, failure to address these operational inefficiencies could lead to continued underperformance. The stock’s valuation, reflected in the high P/E and P/B ratios, indicates that investor expectations are high, necessitating significant improvements in performance metrics to justify current valuations. Ultimately, stakeholder confidence will hinge on the company’s ability to adapt to market dynamics and deliver consistent financial results.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,680 Cr. | 1,085 | 2,114/1,074 | 11.6 | 487 | 0.55 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 798 Cr. | 236 | 391/165 | 16.4 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 54.7 Cr. | 105 | 149/56.6 | 9.80 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,683 Cr. | 207 | 331/198 | 101 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 789 Cr. | 22.2 | 37.3/16.3 | 61.6 | 22.8 | 0.90 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,193.80 Cr | 1,038.95 | 28.97 | 369.04 | 0.47% | 15.21% | 19.87% | 6.67 |
All Competitor Stocks of Bhagiradha Chemicals & Industries Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 131.81 | 126.00 | 122.57 | 100.01 | 122.01 | 74.37 | 110.32 | 110.78 | 100.22 | 102.73 | 122.63 | 123.78 | 134.36 |
| Expenses | 111.47 | 106.39 | 104.28 | 92.80 | 108.45 | 66.19 | 96.37 | 98.94 | 90.47 | 93.43 | 115.39 | 113.78 | 120.15 |
| Operating Profit | 20.34 | 19.61 | 18.29 | 7.21 | 13.56 | 8.18 | 13.95 | 11.84 | 9.75 | 9.30 | 7.24 | 10.00 | 14.21 |
| OPM % | 15.43% | 15.56% | 14.92% | 7.21% | 11.11% | 11.00% | 12.65% | 10.69% | 9.73% | 9.05% | 5.90% | 8.08% | 10.58% |
| Other Income | 0.51 | 0.62 | 0.51 | 0.42 | 0.48 | 1.38 | 2.53 | 3.64 | 5.24 | 5.50 | 6.10 | 3.50 | 0.55 |
| Interest | 0.82 | 0.84 | 1.55 | 1.72 | 2.26 | 1.57 | 2.14 | 1.34 | 1.65 | 2.29 | 1.36 | 2.93 | 3.33 |
| Depreciation | 2.40 | 2.45 | 2.51 | 2.61 | 2.70 | 2.82 | 2.83 | 2.82 | 2.91 | 3.11 | 3.10 | 3.36 | 3.43 |
| Profit before tax | 17.63 | 16.94 | 14.74 | 3.30 | 9.08 | 5.17 | 11.51 | 11.32 | 10.43 | 9.40 | 8.88 | 7.21 | 8.00 |
| Tax % | 28.93% | 28.57% | 33.38% | 33.33% | 30.62% | 28.63% | 29.37% | 36.13% | 24.45% | 24.15% | 41.89% | -14.84% | 26.00% |
| Net Profit | 12.52 | 12.09 | 9.82 | 2.20 | 6.29 | 3.69 | 8.12 | 7.23 | 7.87 | 7.13 | 5.16 | 8.29 | 5.92 |
| EPS in Rs | 1.20 | 1.16 | 0.94 | 0.21 | 0.60 | 0.35 | 0.78 | 0.58 | 0.63 | 0.57 | 0.40 | 0.64 | 0.46 |
Last Updated: December 27, 2025, 8:05 pm
Below is a detailed analysis of the quarterly data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 134.36 Cr.. The value appears strong and on an upward trend. It has increased from 123.78 Cr. (Jun 2025) to 134.36 Cr., marking an increase of 10.58 Cr..
- For Expenses, as of Sep 2025, the value is 120.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 113.78 Cr. (Jun 2025) to 120.15 Cr., marking an increase of 6.37 Cr..
- For Operating Profit, as of Sep 2025, the value is 14.21 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Jun 2025) to 14.21 Cr., marking an increase of 4.21 Cr..
- For OPM %, as of Sep 2025, the value is 10.58%. The value appears strong and on an upward trend. It has increased from 8.08% (Jun 2025) to 10.58%, marking an increase of 2.50%.
- For Other Income, as of Sep 2025, the value is 0.55 Cr.. The value appears to be declining and may need further review. It has decreased from 3.50 Cr. (Jun 2025) to 0.55 Cr., marking a decrease of 2.95 Cr..
- For Interest, as of Sep 2025, the value is 3.33 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.93 Cr. (Jun 2025) to 3.33 Cr., marking an increase of 0.40 Cr..
- For Depreciation, as of Sep 2025, the value is 3.43 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.36 Cr. (Jun 2025) to 3.43 Cr., marking an increase of 0.07 Cr..
- For Profit before tax, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.21 Cr. (Jun 2025) to 8.00 Cr., marking an increase of 0.79 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from -14.84% (Jun 2025) to 26.00%, marking an increase of 40.84%.
- For Net Profit, as of Sep 2025, the value is 5.92 Cr.. The value appears to be declining and may need further review. It has decreased from 8.29 Cr. (Jun 2025) to 5.92 Cr., marking a decrease of 2.37 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.46. The value appears to be declining and may need further review. It has decreased from 0.64 (Jun 2025) to 0.46, marking a decrease of 0.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 220 | 152 | 203 | 183 | 384 | 246 | 318 | 436 | 502 | 407 | 436 | 484 |
| Expenses | 164 | 209 | 148 | 191 | 172 | 343 | 229 | 271 | 367 | 424 | 364 | 398 | 443 |
| Operating Profit | 11 | 11 | 4 | 11 | 12 | 41 | 17 | 47 | 68 | 78 | 43 | 38 | 41 |
| OPM % | 6% | 5% | 3% | 6% | 6% | 11% | 7% | 15% | 16% | 16% | 11% | 9% | 8% |
| Other Income | 1 | 1 | 1 | 2 | -8 | 1 | 4 | 2 | 1 | 2 | 5 | 20 | 16 |
| Interest | 4 | 6 | 7 | 7 | 7 | 8 | 5 | 8 | 9 | 5 | 8 | 7 | 10 |
| Depreciation | 5 | 3 | 4 | 4 | 3 | 5 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| Profit before tax | 2 | 3 | -5 | 3 | -6 | 29 | 9 | 32 | 51 | 65 | 29 | 40 | 33 |
| Tax % | 10% | 17% | -39% | 61% | -77% | 37% | 27% | 27% | 30% | 29% | 30% | 32% | |
| Net Profit | 2 | 3 | -3 | 1 | -1 | 18 | 7 | 23 | 36 | 46 | 20 | 27 | 26 |
| EPS in Rs | 0.31 | 0.40 | -0.51 | 0.16 | -0.14 | 1.78 | 0.63 | 2.28 | 3.50 | 4.46 | 1.95 | 2.11 | 2.07 |
| Dividend Payout % | 26% | 20% | 0% | 0% | 0% | 9% | 0% | 0% | 7% | 9% | 5% | 7% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 50.00% | -200.00% | 133.33% | -200.00% | 1900.00% | -61.11% | 228.57% | 56.52% | 27.78% | -56.52% | 35.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -250.00% | 333.33% | -333.33% | 2100.00% | -1961.11% | 289.68% | -172.05% | -28.74% | -84.30% | 91.52% |
Bhagiradha Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 12% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 40% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 56% |
| 3 Years: | 27% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:31 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 8 | 8 | 8 | 8 | 8 | 10 | 10 | 13 | 13 |
| Reserves | 43 | 44 | 41 | 46 | 94 | 120 | 124 | 148 | 182 | 304 | 407 | 686 | 699 |
| Borrowings | 53 | 71 | 62 | 64 | 61 | 47 | 43 | 62 | 81 | 50 | 61 | 77 | 93 |
| Other Liabilities | 41 | 75 | 71 | 91 | 80 | 98 | 50 | 55 | 71 | 82 | 89 | 138 | 127 |
| Total Liabilities | 142 | 195 | 179 | 206 | 243 | 274 | 225 | 273 | 342 | 446 | 568 | 914 | 932 |
| Fixed Assets | 48 | 52 | 66 | 69 | 77 | 106 | 138 | 145 | 149 | 164 | 176 | 203 | 215 |
| CWIP | 9 | 16 | 0 | 0 | 0 | 4 | 4 | 1 | 3 | 6 | 5 | 15 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 9 | 42 | 80 | 42 | 410 |
| Other Assets | 85 | 127 | 113 | 138 | 166 | 164 | 83 | 119 | 181 | 234 | 306 | 654 | 305 |
| Total Assets | 142 | 195 | 179 | 206 | 243 | 274 | 225 | 273 | 342 | 446 | 568 | 914 | 932 |
Below is a detailed analysis of the balance sheet data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 699.00 Cr.. The value appears strong and on an upward trend. It has increased from 686.00 Cr. (Mar 2025) to 699.00 Cr., marking an increase of 13.00 Cr..
- For Borrowings, as of Sep 2025, the value is 93.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 77.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 127.00 Cr.. The value appears to be improving (decreasing). It has decreased from 138.00 Cr. (Mar 2025) to 127.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 932.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 914.00 Cr. (Mar 2025) to 932.00 Cr., marking an increase of 18.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 215.00 Cr.. The value appears strong and on an upward trend. It has increased from 203.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 410.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2025) to 410.00 Cr., marking an increase of 368.00 Cr..
- For Other Assets, as of Sep 2025, the value is 305.00 Cr.. The value appears to be declining and may need further review. It has decreased from 654.00 Cr. (Mar 2025) to 305.00 Cr., marking a decrease of 349.00 Cr..
- For Total Assets, as of Sep 2025, the value is 932.00 Cr.. The value appears strong and on an upward trend. It has increased from 914.00 Cr. (Mar 2025) to 932.00 Cr., marking an increase of 18.00 Cr..
Notably, the Reserves (699.00 Cr.) exceed the Borrowings (93.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -42.00 | -60.00 | -58.00 | -53.00 | -49.00 | -6.00 | -26.00 | -15.00 | -13.00 | 28.00 | -18.00 | -39.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 82 | 67 | 31 | 71 | 80 | 17 | 68 | 81 | 94 | 95 | 145 |
| Inventory Days | 99 | 139 | 256 | 282 | 281 | 77 | 137 | 97 | 91 | 108 | 166 | 158 |
| Days Payable | 104 | 143 | 216 | 205 | 191 | 110 | 59 | 89 | 73 | 69 | 95 | 135 |
| Cash Conversion Cycle | 66 | 78 | 106 | 108 | 161 | 47 | 95 | 76 | 99 | 132 | 167 | 169 |
| Working Capital Days | 4 | -0 | -19 | -21 | 49 | 16 | -12 | 21 | 32 | 91 | 120 | 395 |
| ROCE % | 7% | 8% | 0% | 8% | 7% | 22% | 7% | 20% | 25% | 22% | 9% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.14 | 17.51 | 44.35 | 43.02 | 28.06 |
| Diluted EPS (Rs.) | 1.14 | 16.10 | 44.35 | 43.02 | 28.06 |
| Cash EPS (Rs.) | 2.14 | 28.06 | 52.82 | 53.37 | 37.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 52.61 | 397.59 | 301.04 | 227.82 | 186.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 52.61 | 397.59 | 301.04 | 227.82 | 186.80 |
| Revenue From Operations / Share (Rs.) | 33.97 | 391.76 | 482.52 | 522.74 | 381.44 |
| PBDIT / Share (Rs.) | 3.56 | 43.81 | 75.52 | 82.94 | 57.02 |
| PBIT / Share (Rs.) | 2.50 | 33.26 | 66.10 | 72.47 | 47.22 |
| PBT / Share (Rs.) | 1.95 | 25.87 | 61.30 | 61.56 | 38.57 |
| Net Profit / Share (Rs.) | 1.07 | 17.51 | 43.39 | 42.89 | 27.98 |
| NP After MI And SOA / Share (Rs.) | 1.07 | 17.51 | 43.39 | 42.89 | 27.98 |
| PBDIT Margin (%) | 10.49 | 11.18 | 15.65 | 15.86 | 14.94 |
| PBIT Margin (%) | 7.34 | 8.49 | 13.69 | 13.86 | 12.38 |
| PBT Margin (%) | 5.73 | 6.60 | 12.70 | 11.77 | 10.11 |
| Net Profit Margin (%) | 3.14 | 4.46 | 8.99 | 8.20 | 7.33 |
| NP After MI And SOA Margin (%) | 3.14 | 4.46 | 8.99 | 8.20 | 7.33 |
| Return on Networth / Equity (%) | 2.03 | 4.40 | 14.41 | 18.82 | 14.97 |
| Return on Capital Employeed (%) | 4.38 | 7.68 | 19.86 | 28.84 | 22.10 |
| Return On Assets (%) | 1.48 | 3.16 | 10.10 | 10.45 | 8.53 |
| Long Term Debt / Equity (X) | 0.04 | 0.04 | 0.05 | 0.05 | 0.12 |
| Total Debt / Equity (X) | 0.12 | 0.14 | 0.15 | 0.42 | 0.37 |
| Asset Turnover Ratio (%) | 0.58 | 0.79 | 1.27 | 1.42 | 1.28 |
| Current Ratio (X) | 1.92 | 2.23 | 2.27 | 1.31 | 1.20 |
| Quick Ratio (X) | 1.26 | 1.34 | 1.36 | 0.79 | 0.66 |
| Inventory Turnover Ratio (X) | 3.65 | 2.69 | 4.23 | 4.66 | 3.68 |
| Dividend Payout Ratio (NP) (%) | 8.97 | 17.13 | 6.91 | 2.32 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 4.48 | 10.68 | 5.67 | 1.86 | 0.00 |
| Earning Retention Ratio (%) | 91.03 | 82.87 | 93.09 | 97.68 | 0.00 |
| Cash Earning Retention Ratio (%) | 95.52 | 89.32 | 94.33 | 98.14 | 0.00 |
| Interest Coverage Ratio (X) | 6.50 | 5.93 | 15.74 | 7.61 | 5.75 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 3.37 | 10.04 | 4.93 | 3.69 |
| Enterprise Value (Cr.) | 3659.46 | 1726.83 | 1291.27 | 923.65 | 478.11 |
| EV / Net Operating Revenue (X) | 8.31 | 4.24 | 2.57 | 2.12 | 1.50 |
| EV / EBITDA (X) | 79.16 | 37.88 | 16.43 | 13.36 | 10.06 |
| MarketCap / Net Operating Revenue (X) | 8.18 | 4.11 | 2.48 | 1.94 | 1.32 |
| Retention Ratios (%) | 91.02 | 82.86 | 93.08 | 97.67 | 0.00 |
| Price / BV (X) | 5.28 | 4.05 | 3.98 | 4.46 | 2.70 |
| Price / Net Operating Revenue (X) | 8.18 | 4.11 | 2.48 | 1.94 | 1.32 |
| EarningsYield | 0.00 | 0.01 | 0.03 | 0.04 | 0.05 |
After reviewing the key financial ratios for Bhagiradha Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 17.51 (Mar 24) to 1.14, marking a decrease of 16.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 16.10 (Mar 24) to 1.14, marking a decrease of 14.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 3. It has decreased from 28.06 (Mar 24) to 2.14, marking a decrease of 25.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.97. It has decreased from 391.76 (Mar 24) to 33.97, marking a decrease of 357.79.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.56. This value is within the healthy range. It has decreased from 43.81 (Mar 24) to 3.56, marking a decrease of 40.25.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.50. This value is within the healthy range. It has decreased from 33.26 (Mar 24) to 2.50, marking a decrease of 30.76.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 25.87 (Mar 24) to 1.95, marking a decrease of 23.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
- For PBDIT Margin (%), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.49, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 7.34. This value is below the healthy minimum of 10. It has decreased from 8.49 (Mar 24) to 7.34, marking a decrease of 1.15.
- For PBT Margin (%), as of Mar 25, the value is 5.73. This value is below the healthy minimum of 10. It has decreased from 6.60 (Mar 24) to 5.73, marking a decrease of 0.87.
- For Net Profit Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 5. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 8. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 15. It has decreased from 4.40 (Mar 24) to 2.03, marking a decrease of 2.37.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 4.38, marking a decrease of 3.30.
- For Return On Assets (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 3.16 (Mar 24) to 1.48, marking a decrease of 1.68.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.12, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.58. It has decreased from 0.79 (Mar 24) to 0.58, marking a decrease of 0.21.
- For Current Ratio (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.92, marking a decrease of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 4. It has increased from 2.69 (Mar 24) to 3.65, marking an increase of 0.96.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 20. It has decreased from 17.13 (Mar 24) to 8.97, marking a decrease of 8.16.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 20. It has decreased from 10.68 (Mar 24) to 4.48, marking a decrease of 6.20.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.03. This value exceeds the healthy maximum of 70. It has increased from 82.87 (Mar 24) to 91.03, marking an increase of 8.16.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.52. This value exceeds the healthy maximum of 70. It has increased from 89.32 (Mar 24) to 95.52, marking an increase of 6.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.50. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 6.50, marking an increase of 0.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has decreased from 3.37 (Mar 24) to 2.95, marking a decrease of 0.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,659.46. It has increased from 1,726.83 (Mar 24) to 3,659.46, marking an increase of 1,932.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has increased from 4.24 (Mar 24) to 8.31, marking an increase of 4.07.
- For EV / EBITDA (X), as of Mar 25, the value is 79.16. This value exceeds the healthy maximum of 15. It has increased from 37.88 (Mar 24) to 79.16, marking an increase of 41.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
- For Retention Ratios (%), as of Mar 25, the value is 91.02. This value exceeds the healthy maximum of 70. It has increased from 82.86 (Mar 24) to 91.02, marking an increase of 8.16.
- For Price / BV (X), as of Mar 25, the value is 5.28. This value exceeds the healthy maximum of 3. It has increased from 4.05 (Mar 24) to 5.28, marking an increase of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhagiradha Chemicals & Industries Ltd:
- Net Profit Margin: 3.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.38% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.03% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 101 (Industry average Stock P/E: 28.97)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.12
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Unit No.1011A, Level 1, Sky One (Wing A), Hyderabad Telangana 500032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kishor Shah | Chairman(NonExe.&Ind.Director) |
| Mr. Chandra Sekhar Singavarapu | Managing Director |
| Mr. Arvind Kumar Anegondi | Executive Director & CEO |
| Mr. Krishna Rao S V Gadepalli | Ind. Non-Executive Director |
| Dr. G Aruna | Ind. Non-Executive Woman Director |
| Mr. Suresh Kumar Somani | Non Exe.Non Ind.Director |
| Mrs. Lalitha Sree Singavarapu | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Bhagiradha Chemicals & Industries Ltd?
Bhagiradha Chemicals & Industries Ltd's intrinsic value (as of 22 January 2026) is ₹196.23 which is 5.20% lower the current market price of ₹207.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,683 Cr. market cap, FY2025-2026 high/low of ₹331/198, reserves of ₹699 Cr, and liabilities of ₹932 Cr.
What is the Market Cap of Bhagiradha Chemicals & Industries Ltd?
The Market Cap of Bhagiradha Chemicals & Industries Ltd is 2,683 Cr..
What is the current Stock Price of Bhagiradha Chemicals & Industries Ltd as on 22 January 2026?
The current stock price of Bhagiradha Chemicals & Industries Ltd as on 22 January 2026 is ₹207.
What is the High / Low of Bhagiradha Chemicals & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bhagiradha Chemicals & Industries Ltd stocks is ₹331/198.
What is the Stock P/E of Bhagiradha Chemicals & Industries Ltd?
The Stock P/E of Bhagiradha Chemicals & Industries Ltd is 101.
What is the Book Value of Bhagiradha Chemicals & Industries Ltd?
The Book Value of Bhagiradha Chemicals & Industries Ltd is 54.9.
What is the Dividend Yield of Bhagiradha Chemicals & Industries Ltd?
The Dividend Yield of Bhagiradha Chemicals & Industries Ltd is 0.07 %.
What is the ROCE of Bhagiradha Chemicals & Industries Ltd?
The ROCE of Bhagiradha Chemicals & Industries Ltd is 7.44 %.
What is the ROE of Bhagiradha Chemicals & Industries Ltd?
The ROE of Bhagiradha Chemicals & Industries Ltd is 4.91 %.
What is the Face Value of Bhagiradha Chemicals & Industries Ltd?
The Face Value of Bhagiradha Chemicals & Industries Ltd is 1.00.